Benitec Biopharma Inc. (BNTC)
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
$84.02M
Dr. Jerel A. Banks M.D., Ph.D.
18.00
Hayward, CA
Jul 11, 2012
-0.87
$-9.60
4.12
4.18
-166,861.54%
-0.98
-0.02
1.85
6,323.21
4.18
-144.62%
-175.36%
Similar stocks (8)
Capricor Therapeutics, Inc.
CAPR
Aileron Therapeutics, Inc.
ALRN
NextCure, Inc.
NXTC
Virios Therapeutics, Inc.
VIRI
Bio-Path Holdings, Inc.
BPTH
ZyVersa Therapeutics, Inc.
ZVSA
eFFECTOR Therapeutics, Inc.
EFTR
Navidea Biopharmaceuticals, Inc.
NAVB
ETF Exposure (4)
Simplify Health Care ETF
PINK
0.42962599999999995%
iShares Micro-Cap ETF
IWC
0.00569%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (8)
Capricor Therapeutics, Inc.
CAPR
Aileron Therapeutics, Inc.
ALRN
NextCure, Inc.
NXTC
Virios Therapeutics, Inc.
VIRI
Bio-Path Holdings, Inc.
BPTH
ZyVersa Therapeutics, Inc.
ZVSA
eFFECTOR Therapeutics, Inc.
EFTR
Navidea Biopharmaceuticals, Inc.
NAVB
ETF Exposure (4)
Simplify Health Care ETF
PINK
0.42962599999999995%
iShares Micro-Cap ETF
IWC
0.00569%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%